Annual Retained Earnings
-$1.22 B
-$318.76 M-35.32%
December 31, 2024
Summary
- As of March 12, 2025, SNDX annual retained earnings is -$1.22 billion, with the most recent change of -$318.76 million (-35.32%) on December 31, 2024.
- During the last 3 years, SNDX annual retained earnings has fallen by -$677.46 million (-124.60%).
- SNDX annual retained earnings is now -1444.71% below its all-time high of -$79.05 million, reached on December 31, 2012.
Performance
SNDX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$1.22 B
-$94.17 M-8.36%
December 31, 2024
Summary
- As of March 12, 2025, SNDX quarterly retained earnings is -$1.22 billion, with the most recent change of -$94.17 million (-8.36%) on December 31, 2024.
- Over the past year, SNDX quarterly retained earnings has dropped by -$94.17 million (-8.36%).
- SNDX quarterly retained earnings is now -799.85% below its all-time high of -$135.71 million, reached on December 31, 2013.
Performance
SNDX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
SNDX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.3% | -8.4% |
| 3 y3 years | -124.6% | -8.4% |
| 5 y5 years | -146.5% | -8.4% |
SNDX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -124.6% | at low | -124.6% | at low |
| 5 y | 5-year | -146.5% | at low | -146.5% | at low |
| alltime | all time | -1444.7% | at low | -799.9% | at low |
Syndax Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -$1.22 B(+35.3%) | -$1.22 B(+8.4%) |
| Sep 2024 | - | -$1.13 B(+8.1%) |
| Jun 2024 | - | -$1.04 B(+7.0%) |
| Mar 2024 | - | -$974.80 M(+8.0%) |
| Dec 2023 | -$902.40 M(+30.2%) | -$902.40 M(+8.7%) |
| Sep 2023 | - | -$829.93 M(+6.6%) |
| Jun 2023 | - | -$778.78 M(+6.1%) |
| Mar 2023 | - | -$734.17 M(+5.9%) |
| Dec 2022 | -$693.04 M(+27.5%) | -$693.04 M(+6.0%) |
| Sep 2022 | - | -$653.85 M(+5.7%) |
| Jun 2022 | - | -$618.44 M(+6.5%) |
| Mar 2022 | - | -$580.87 M(+6.8%) |
| Dec 2021 | -$543.70 M(-4.4%) | -$543.70 M(-15.0%) |
| Sep 2021 | - | -$639.90 M(+3.3%) |
| Jun 2021 | - | -$619.26 M(+3.8%) |
| Mar 2021 | - | -$596.35 M(+4.9%) |
| Dec 2020 | -$568.63 M(+14.8%) | -$568.63 M(+3.7%) |
| Sep 2020 | - | -$548.21 M(+3.9%) |
| Jun 2020 | - | -$527.77 M(+3.3%) |
| Mar 2020 | - | -$510.71 M(+3.1%) |
| Dec 2019 | -$495.47 M | -$495.47 M(+2.9%) |
| Sep 2019 | - | -$481.47 M(+2.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | -$468.64 M(+3.3%) |
| Mar 2019 | - | -$453.73 M(+3.3%) |
| Dec 2018 | -$439.42 M(+20.0%) | -$439.42 M(+4.5%) |
| Sep 2018 | - | -$420.59 M(+4.3%) |
| Jun 2018 | - | -$403.25 M(+4.8%) |
| Mar 2018 | - | -$384.86 M(+5.1%) |
| Dec 2017 | -$366.11 M(+19.9%) | -$366.11 M(+5.5%) |
| Sep 2017 | - | -$347.01 M(+4.5%) |
| Jun 2017 | - | -$331.92 M(+4.3%) |
| Mar 2017 | - | -$318.28 M(+4.3%) |
| Dec 2016 | -$305.29 M(+17.6%) | -$305.29 M(+3.7%) |
| Sep 2016 | - | -$294.48 M(+5.4%) |
| Jun 2016 | - | -$279.51 M(+3.1%) |
| Mar 2016 | - | -$271.15 M(+4.4%) |
| Dec 2015 | -$259.68 M(+62.5%) | -$259.68 M(+3.0%) |
| Sep 2015 | - | -$252.09 M(+57.8%) |
| Dec 2014 | -$159.80 M(+17.8%) | -$159.80 M(+3.1%) |
| Sep 2014 | - | -$155.02 M(+5.8%) |
| Jun 2014 | - | -$146.48 M(+4.1%) |
| Mar 2014 | - | -$140.73 M(+3.7%) |
| Dec 2013 | -$135.71 M(+71.7%) | -$135.71 M |
| Dec 2012 | -$79.05 M | - |
FAQ
- What is Syndax Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals annual retained earnings year-on-year change?
- What is Syndax Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals quarterly retained earnings year-on-year change?
What is Syndax Pharmaceuticals annual retained earnings?
The current annual retained earnings of SNDX is -$1.22 B
What is the all time high annual retained earnings for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high annual retained earnings is -$79.05 M
What is Syndax Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, SNDX annual retained earnings has changed by -$318.76 M (-35.32%)
What is Syndax Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of SNDX is -$1.22 B
What is the all time high quarterly retained earnings for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high quarterly retained earnings is -$135.71 M
What is Syndax Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, SNDX quarterly retained earnings has changed by -$94.17 M (-8.36%)